Champions Oncology Inc. Daily Stock Analysis

Daily Stock Analysis, CSBR, Champions Oncology Inc, priceseries

Champions Oncology Inc. Daily Stock Analysis
Stock Information
Open
8.17
Close
8.53
High
8.63
Low
8.10
Previous Close
8.14
Daily Price Gain
0.39
YTD High
9.13
YTD High Date
Jan 4, 2022
YTD Low
7.10
YTD Low Date
Feb 11, 2022
YTD Price Change
0.05
YTD Gain
0.59%
52 Week High
14.68
52 Week High Date
Mar 16, 2021
52 Week Low
7.10
52 Week Low Date
Feb 11, 2022
52 Week Price Change
-2.49
52 Week Gain
-22.60%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 30. 2016
2.53
Jan 18. 2017
3.28
11 Trading Days
29.77%
Link
LONG
Jan 25. 2017
3.66
Feb 7. 2017
4.14
9 Trading Days
13.19%
Link
LONG
Jun 15. 2017
2.46
Jun 29. 2017
2.64
10 Trading Days
7.48%
Link
LONG
Jul 28. 2017
2.78
Aug 16. 2017
3.09
13 Trading Days
11.20%
Link
LONG
Nov 22. 2017
3.67
Nov 27. 2017
3.90
2 Trading Days
6.40%
Link
LONG
Apr 25. 2018
4.09
May 11. 2018
4.34
12 Trading Days
6.22%
Link
LONG
May 30. 2018
4.36
Jun 29. 2018
6.57
22 Trading Days
50.73%
Link
LONG
Jul 17. 2018
7.30
Jul 30. 2018
8.18
9 Trading Days
12.01%
Link
LONG
Sep 17. 2018
11.57
Sep 21. 2018
12.17
4 Trading Days
5.21%
Link
LONG
Jan 4. 2019
8.36
Jan 23. 2019
9.55
12 Trading Days
14.25%
Link
LONG
Nov 29. 2019
5.76
Dec 11. 2019
6.72
8 Trading Days
16.63%
Link
LONG
Mar 25. 2020
5.65
Apr 16. 2020
7.04
15 Trading Days
24.57%
Link
LONG
May 4. 2020
8.10
May 18. 2020
8.55
10 Trading Days
5.54%
Link
LONG
Nov 13. 2020
10.64
Nov 24. 2020
11.42
7 Trading Days
7.37%
Link
Company Information
Stock Symbol
CSBR
Exchange
NasdaqCM
Company URL
http://www.championsoncology.com
Company Phone
410-369-0365
CEO
Ronnie Morris
Headquarters
Maryland
Business Address
855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD 21205
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0000771856
About

Champions Oncology, Inc. is engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. It operates in the Personalized Oncology Solutions and Translational Oncology Solutions segments. The Personalized Oncology Solutions segment provides services to physicians and patients looking for information to help guide the development of a personalized treatment plans. The Translational Oncology Solutions segment provides services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development that will lower the cost and increase the speed of developing new drugs and increasing the adoption of existing drugs. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.

Description

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. It also offers POS products, including personalized tumor boards that are designed to provide access to oncologists with expertise in particular tumor types; and provides access to gene sequencing that analyzes the genetic makeup of patient's tumor for the purpose of identifying useful drugs. In addition, the company offers Translational Oncology Solutions (TOS), including a preclinical Tumorgraft platform to pharmaceutical and biotechnology companies that use vivo studies, which rely on implanting multiple tumors from TumorBank in mice and testing the therapy of interest on tumors. Further, it provides a bank of tumors that are acquired, collected, processed, validated, and stored for the use in TOS. The company markets its products through Internet, word of mouth, and a network of sales force. It serves patients, physicians, and drug development companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011 to reflect its new focus on developing technologies to personalize the development and use of oncology drugs. Champions Oncology, Inc. is headquartered in Hackensack, New Jersey.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading